Funder
National Natural Science Foundation of China
Health Bureau of Henan Province, P.R. China
foundation and frontier research grant of Henan provincial science and technology bureau, P.R. China
Subject
Cancer Research,Oncology,Hematology
Reference13 articles.
1. Management of patients with acute promyelocytic leukemia;Kayser;Leukemia,2018
2. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups;Sanz;Blood,2000
3. Acute myeloid leukemia, Version 3.2017, NCCN clinical practice guidelines in oncology;O’Donnell;J. Compr. Canc. Netw.,2017
4. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients;Testa;Ann. Hematol.,2016
5. Treatment advances have not improved the early death rate in acute promyelocytic leukemia;McClellan;Haematologica,2012
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献